Healthcare
Live Price
Offline$8.56
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 16, 2026
Coverage: 253 bars · Jun 23, 2025 → Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
SMS Co., Ltd. (SMSZF) is a Healthcare stock with a market cap of $142.16B and listed on OTC. The stock last traded around $8.56 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 16, 2026). Baseline metrics include revenue growth of +6.9%, EPS growth of -345.4%, a dividend yield of 1.7%. What stands out right now is revenue +6.9%, EPS -345.4%, free cash flow +401.9% with operating margin 10.1% and ROIC 19.0%. The dividend is present but secondary, with a yield around 1.7%. Valuation is more restrained than many high-expectation growth names at price/sales 2.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SMSZF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SMSZF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SMSZF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SMSZF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$36.0B
-7.6% YoY
FY Net Income
$4.8B
-11.2% YoY
Free Cash Flow
$42.8M
-33.2% YoY
Revenue Growth
+6.9%
EPS Growth
-345.4%
Gross Margin
81.1%
Net Margin
-22.1%
Income statement
JPY
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 61.0B | 54.0B | 344M | 38.9B | 36.0B |
| Gross Profit | 53.9B | 47.5B | 280M | 263M | 270M |
| Operating Income | 6.3B | 8.3B | 7.3B | 6.3B | 5.5B |
| EBITDA | 12.1B | 11.7B | 10.2B | 8.8B | 7.7B |
| Net Income | 6.1B | 7.2B | 6.4B | 5.4B | 4.8B |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
JPY
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 16.2B | 18.2B | 122M | 116M | 92M |
| Total Assets | 76.5B | 72.5B | 490M | 465M | 447M |
| Total Liabilities | 29.2B | 28.2B | 201M | 219M | 242M |
| Shareholder Equity | 47.3B | 44.3B | 38.4B | 30.0B | 22.7B |
| Total Debt | 8.1B | 6.4B | 8.3B | 10.4B | 13.5B |
| Net Debt | -8.1B | -11.8B | -59M | -31M | 31M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
61M
-24.0% YoY
Capital Expenditures
18M
-11.4% YoY
Free Cash Flow
43M
-33.2% YoY
Key ratios
Gross Margin
81.1%
Operating Margin
10.1%
Net Margin
-22.1%
ROE
-36.0%
Debt / Equity
0.27x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.